Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Cash from Financing Activities (2016 - 2025)

IGC Pharma has reported Cash from Financing Activities over the past 16 years, most recently at $3.1 million for Q3 2025.

  • Quarterly Cash from Financing Activities rose 291.69% to $3.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Sep 2025, up 28.84% year-over-year, with the annual reading at $4.5 million for FY2025, 26.31% up from the prior year.
  • Cash from Financing Activities was $3.1 million for Q3 2025 at IGC Pharma, up from $851000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $14.2 million in Q1 2021 and troughed at -$1000.0 in Q4 2021.
  • The 5-year median for Cash from Financing Activities is $696500.0 (2021), against an average of $1.7 million.
  • Year-over-year, Cash from Financing Activities tumbled 100.14% in 2022 and then skyrocketed 250800.0% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1000.0 in 2021, then skyrocketed by 10300.0% to $102000.0 in 2022, then tumbled by 100.98% to -$1000.0 in 2023, then surged by 34600.0% to $345000.0 in 2024, then soared by 801.45% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for IGC's Cash from Financing Activities are $3.1 million (Q3 2025), $851000.0 (Q2 2025), and $805000.0 (Q1 2025).